Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0036690 (
sepsis
)
59,461
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
HIV patients have an increased risk to develop
sepsis
and HIV infection affects several components of the immune system involved in
sepsis
pathogenesis. We hypothesized that HIV infection might aggrevate the aberrant immune response during
sepsis
, so we aimed to determine the impact of HIV infection on the genomic host response to
sepsis
. We compared whole blood leukocyte gene expression profiles among
sepsis
patients with or without HIV co-infection in the intensive care unit (ICU) and validated our findings in a cohort of patients admitted to the same ICUs in a different time frame. To examine the influence of HIV infection per se, we also determined the expression of genes of interest in a cohort of asymptomatic HIV patients. We identified a predominantly common host response in
sepsis
patients with or without HIV co-infection. HIV positive
sepsis
patients in both ICU cohorts showed overexpression of genes involved in granzyme signaling (GZMA, GZMB), cytotoxic T-cell signaling (CD8A,
CD8B
) and T-cell inhibitory signaling (LAG3), compared to HIV negative patients. Enhanced expression of CD8A,
CD8B
and LAG3 was also unmasked in asymptomatic HIV patients. Plasma levels of granzymes in
sepsis
patients were largely below detection limit, without differences according to HIV status. These results demonstrate that
sepsis
is characterized by a massive common response with few differences between HIV positive and HIV negative
sepsis
patients. Observed differences in granzyme signaling, cytotoxic T-cell signaling and T-cell inhibitory signaling appear to be changes commonly observed in asymptomatic HIV patients which persist during
sepsis
.
...
PMID:The Impact of HIV Co-Infection on the Genomic Response to Sepsis. 2687 9